The Dermatology Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) https://www.globalinforesearch.com/reports/696171/dermatology-drug
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Dermatology Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Psoriasis accounting for % of the Dermatology Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While External Use segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Dermatology Drug include AbbVie, Johnson & Johnson, Bayer, Galderma, and Bristol-Myers Squibb, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Dermatology Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
External Use
Oral
Injection
Market segment by Application, can be divided into
Psoriasis
Skin Infections
Acne
Dermatitis
Others
Market segment by players, this report covers
AbbVie
Johnson & Johnson
Bayer
Galderma
Bristol-Myers Squibb
Novartis
Pfizer
Merz Pharma
Valeant
LEO Pharma
GlaxoSmithKline
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dermatology Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dermatology Drug, with price, sales, revenue and global market share of Dermatology Drug from 2019 to 2022.
Chapter 3, the Dermatology Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dermatology Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, end user, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Dermatology Drug market forecast, by regions, type and end user, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Dermatology Drug.
Chapter 13, 14, and 15, to describe Dermatology Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
About Us:
GlobaI Info Research（GIR） is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Dermatology Drug
1.2 Classification of Dermatology Drug by Type
1.2.1 Overview: Global Dermatology Drug Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Dermatology Drug Revenue Market Share by Type in 2021
1.2.3 External Use
1.2.4 Oral
1.2.5 Injection
1.3 Global Dermatology Drug Market by Application
1.3.1 Overview: Global Dermatology Drug Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Psoriasis
1.3.3 Skin Infections
1.3.4 Acne
1.3.5 Dermatitis
1.3.6 Others
1.4 Global Dermatology Drug Market Size & Forecast
1.5 Global Dermatology Drug Market Size and Forecast by Region
1.5.1 Global Dermatology Drug Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Dermatology Drug Market Size by Region, (2017-2022)
1.5.3 North America Dermatology Drug Market Size and Prospect (2017-2028)
1.5.4 Europe Dermatology Drug Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Dermatology Drug Market Size and Prospect (2017-2028)
1.5.6 South America Dermatology Drug Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Dermatology Drug Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Dermatology Drug Market Drivers
1.6.2 Dermatology Drug Market Restraints
1.6.3 Dermatology Drug Trends Analysis
2 Company Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Dermatology Drug Product and Solutions
2.1.4 AbbVie Dermatology Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 AbbVie Recent Developments and Future Plans
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Dermatology Drug Product and Solutions
2.2.4 Johnson & Johnson Dermatology Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Johnson & Johnson Recent Developments and Future Plans
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Dermatology Drug Product and Solutions
2.3.4 Bayer Dermatology Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Bayer Recent Developments and Future Plans
2.4 Galderma
2.4.1 Galderma Details
2.4.2 Galderma Major Business
2.4.3 Galderma Dermatology Drug Product and Solutions
2.4.4 Galderma Dermatology Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Galderma Recent Developments and Future Plans
2.5 Bristol-Myers Squibb
2.5.1 Bristol-Myers Squibb Details
2.5.2 Bristol-Myers Squibb Major Business
2.5.3 Bristol-Myers Squibb Dermatology Drug Product and Solutions
2.5.4 Bristol-Myers Squibb Dermatology Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Dermatology Drug Product and Solutions
2.6.4 Novartis Dermatology Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Novartis Recent Developments and Future Plans
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Dermatology Drug Product and Solutions
2.7.4 Pfizer Dermatology Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Pfizer Recent Developments and Future Plans
2.8 Merz Pharma
2.8.1 Merz Pharma Details
2.8.2 Merz Pharma Major Business
2.8.3 Merz Pharma Dermatology Drug Product and Solutions
2.8.4 Merz Pharma Dermatology Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Merz Pharma Recent Developments and Future Plans
2.9 Valeant
2.9.1 Valeant Details
2.9.2 Valeant Major Business
2.9.3 Valeant Dermatology Drug Product and Solutions
2.9.4 Valeant Dermatology Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Valeant Recent Developments and Future Plans
2.10 LEO Pharma
2.10.1 LEO Pharma Details
2.10.2 LEO Pharma Major Business
2.10.3 LEO Pharma Dermatology Drug Product and Solutions
2.10.4 LEO Pharma Dermatology Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 LEO Pharma Recent Developments and Future Plans
2.11 GlaxoSmithKline
2.11.1 GlaxoSmithKline Details
2.11.2 GlaxoSmithKline Major Business
2.11.3 GlaxoSmithKline Dermatology Drug Product and Solutions
2.11.4 GlaxoSmithKline Dermatology Drug Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 GlaxoSmithKline Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Dermatology Drug Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Dermatology Drug Players Market Share in 2021
3.2.2 Top 10 Dermatology Drug Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Dermatology Drug Players Head Office, Products and Services Provided
3.4 Dermatology Drug Mergers & Acquisitions
3.5 Dermatology Drug New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Dermatology Drug Revenue and Market Share by Type (2017-2022)
4.2 Global Dermatology Drug Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Dermatology Drug Revenue Market Share by Application (2017-2022)
5.2 Global Dermatology Drug Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Dermatology Drug Revenue by Type (2017-2028)
6.2 North America Dermatology Drug Revenue by Application (2017-2028)
6.3 North America Dermatology Drug Market Size by Country
6.3.1 North America Dermatology Drug Revenue by Country (2017-2028)
6.3.2 United States Dermatology Drug Market Size and Forecast (2017-2028)
6.3.3 Canada Dermatology Drug Market Size and Forecast (2017-2028)
6.3.4 Mexico Dermatology Drug Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Dermatology Drug Revenue by Type (2017-2028)
7.2 Europe Dermatology Drug Revenue by Application (2017-2028)
7.3 Europe Dermatology Drug Market Size by Country
7.3.1 Europe Dermatology Drug Revenue by Country (2017-2028)
7.3.2 Germany Dermatology Drug Market Size and Forecast (2017-2028)
7.3.3 France Dermatology Drug Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Dermatology Drug Market Size and Forecast (2017-2028)
7.3.5 Russia Dermatology Drug Market Size and Forecast (2017-2028)
7.3.6 Italy Dermatology Drug Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Dermatology Drug Revenue by Type (2017-2028)
8.2 Asia-Pacific Dermatology Drug Revenue by Application (2017-2028)
8.3 Asia-Pacific Dermatology Drug Market Size by Region
8.3.1 Asia-Pacific Dermatology Drug Revenue by Region (2017-2028)
8.3.2 China Dermatology Drug Market Size and Forecast (2017-2028)
8.3.3 Japan Dermatology Drug Market Size and Forecast (2017-2028)
8.3.4 South Korea Dermatology Drug Market Size and Forecast (2017-2028)
8.3.5 India Dermatology Drug Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Dermatology Drug Market Size and Forecast (2017-2028)
8.3.7 Australia Dermatology Drug Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Dermatology Drug Revenue by Type (2017-2028)
9.2 South America Dermatology Drug Revenue by Application (2017-2028)
9.3 South America Dermatology Drug Market Size by Country
9.3.1 South America Dermatology Drug Revenue by Country (2017-2028)
9.3.2 Brazil Dermatology Drug Market Size and Forecast (2017-2028)
9.3.3 Argentina Dermatology Drug Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Dermatology Drug Revenue by Type (2017-2028)
10.2 Middle East & Africa Dermatology Drug Revenue by Application (2017-2028)
10.3 Middle East & Africa Dermatology Drug Market Size by Country
10.3.1 Middle East & Africa Dermatology Drug Revenue by Country (2017-2028)
10.3.2 Turkey Dermatology Drug Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Dermatology Drug Market Size and Forecast (2017-2028)
10.3.4 UAE Dermatology Drug Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Contact US
Global Info Research
E-mail: report@globalinforesearch.com
Tel: +86-13660489451 00852-58197708(HK)
WeChat: 17665052062
Add:FLAT/RM A 9/F SILVERCORP INTERNATIONAL TOWER 707-713 NATHAN ROAD MONGKOK KL HONG KONG
Website: http://www.globalinforesearch.com
No comments:
Post a Comment